Regulatory Compliance

On PHP Programs & A Follow-Up On SB 382…

NC Senate Bill 382 (SB 382) had several provisions but perhaps the one which drew the most attention was that which might empower the NC State Board of Dental Examiners (NCBDE) to compel licensees to undergo physical examination and/or testing without a court order. Ostensibly this bill might relate to mental health and substance abuse […]

On PHP Programs & A Follow-Up On SB 382… Read More »

NC Auditor Beth Wood Resigns Amid Controversy Following 2023 NC Medical Board Audit

In 2023 Beth Wood, the North Carolina State Auditor, initiated an audit of the North Carolina Medical Board (NCMB) that revealed significant issues in the board’s oversight of physician misconduct, including obstruction of access to investigation records. This raised concerns about the board’s effectiveness in protecting the public. Subsequently, Wood faced accusations of misusing state-owned

NC Auditor Beth Wood Resigns Amid Controversy Following 2023 NC Medical Board Audit Read More »

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners

The US Drug Enforcement Administration (DEA) has outlined an eight-hour training requirement on the treatment and management of opioid patients. The Medication Access and Training Expansion Act mandates the training for all DEA-registered providers, with the deadline for completion set for the date of a practitioner’s next scheduled DEA registration submission beginning on June 27. Graduates from medical and dental schools are exempt from the requirement. The training does not have to occur in one session, and courses previously undertaken in accordance with state-mandated continuing education will apply.

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners Read More »

FDA Approves OTC Naloxone

This article discusses the recent approval of the first over-the-counter naloxone nasal spray for use in reversing opioid overdoses. The U.S. Food and Drug Administration (FDA) has approved the first over-the-counter (OTC) naloxone nasal spray, Narcan, to help prevent opioid overdoses. The nasal spray is intended for use in adults and adolescents, and the FDA

FDA Approves OTC Naloxone Read More »

NC To Mandate Continuing Education On Practitioner Substance Abuse And Mental Health

The NC Legislature has adopted NCAC 16R(I).0206 requiring NC dentists and hygienists to complete 1 hour of continuing education on practitioner substance abuse and mental health every 2 years. This requirement is NOT satisfied by the completion of an approved controlled substance prescribing course. This new requirement exclusively impacts NC dental licensees as no other

NC To Mandate Continuing Education On Practitioner Substance Abuse And Mental Health Read More »

2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain

On Thursday, November 3, 2022, the CDC released it’s most recent recommendations for the prescribing of opioids for acute, subacute, and chronic pain. The new guidelines provide 12 recommendations relating to the use of opioids and mostly favor a more individualized approach. However, the CDC issued a guideline much stronger than the 2016 version defining

2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain Read More »

Shopping Cart
Scroll to Top
0